SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-083605
Filing Date
2024-04-01
Accepted
2024-04-01 17:21:30
Documents
5
Effectiveness Date
2024-04-01

Document Format Files

Seq Description Document Type Size
1 S-8 d816522ds8.htm S-8 49062
2 EX-5.1 d816522dex51.htm EX-5.1 11102
3 EX-23.2 d816522dex232.htm EX-23.2 1444
4 EX-FILING FEES d816522dexfilingfees.htm EX-FILING FEES 19350
5 GRAPHIC g816522g0329041441262.jpg GRAPHIC 2302
  Complete submission text file 0001193125-24-083605.txt   85460
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278440 | Film No.: 24811038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)